Fluid resuscitation in acute medicine: What is the current situation?

Journal of Internal Medicine

Volumn 277, Issue 1, 2015, Pages 58-68

  Myburgh, J A ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

Author keywords

Albumin; Colloids; Crystalloids; Fluids; Hydroxyethyl starch; Saline

Indexed keywords

ALBUMINOID; COLLOID; CRYSTALLOID; HETASTARCH DERIVATIVE; ISOTONIC SOLUTION; ORAL REHYDRATION SOLUTION;

ADMINISTRATION AND DOSAGE; COLLOID; EMERGENCY MEDICINE; FEMALE; FLUID THERAPY; FORECASTING; HUMAN; INTENSIVE CARE; MALE; MORTALITY; PRACTICE GUIDELINE; PROCEDURES; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESUSCITATION; RISK ASSESSMENT; STANDARDS; SURVIVAL RATE; TREATMENT OUTCOME; TRENDS;

ALBUMINS; COLLOIDS; EMERGENCY MEDICINE; FEMALE; FLUID THERAPY; FORECASTING; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; INTENSIVE CARE; ISOTONIC SOLUTIONS; MALE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REHYDRATION SOLUTIONS; RESUSCITATION; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84916897330     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12326     Document Type: Review

References (57)

1. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med 2013; 369: 1243-51.
2. Finfer S, Liu B, Taylor C et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care 2010; 14: R185.
3. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247-56.
4. Myburgh JA, Finfer S, Bellomo R et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367: 1901-11.
5. Perner A, Haase N, Guttormsen AB et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124-34.
6. Maitland K, Kiguli S, Opoka R et al. Mortality after fluid bolus in African children with shock. N Engl J Med 2011; 364: 2483-95.
7. Lewins R. Saline injections into the veins. London Medical Gazette 1832; 257-68.
8. Lee JA. Sydney Ringer (1834-1910) and Alexis Hartmann (1898-1964). Anaesthesia 1981; 36: 1115-21.
9. Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutr 2008; 27: 179-88.
10. Starling EH. On the absorption of fluids from connective tissue spaces. J Physiol 1896; 19: 312-26.
11. Krogh A, Landis EM, Turner AH. The movement of fluid through the human capillary wall in relation to venous pressure and to the colloid osmotic pressure of the blood. J Clin Invest 1932; 11: 63-95.
12. Woodcock TE, Woodcock TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 2012; 108: 384-94.
13. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998; 317: 235-40.
14. Jones D, McEvoy S, Merz TM et al. International albumin use: 1995 to 2006. Anaesth Intensive Care 2010; 38: 266-73.
15. Finfer S, Bellomo R, McEvoy S et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. BMJ 2006; 333: 1044.
16. Myburgh J, Cooper DJ, Finfer S et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357: 874-84.
17. Cooper DJ, Myburgh J, Heritier S et al. Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma 2013; 30: 512-8.
18. Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011; 37: 86-96.
19. Caironi P, Tognoni G, Masson S et al. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 2014; 370: 1412-21.
20. Dickenmann M, Oettl T, Mihatsch MJ. Osmotic nephrosis: acute kidney injury with accumulation of proximal tubular lysosomes due to administration of exogenous solutes. Am J Kidney Dis 2008; 51: 491-503.
21. Bellmann R, Feistritzer C, Wiedermann CJ. Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies. Clin Pharmacokinet 2012; 51: 225-36.
22. Cittanova ML, Leblanc I, Legendre C, Mouquet C, Riou B, Coriat P. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620-2.
23. Schortgen F, Lacherade JC, Bruneel F et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357: 911-6.
24. Brunkhorst FM, Engel C, Bloos F et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125-39.
25. James MF, Michell WL, Joubert IA, Nicol AJ, Navsaria PH, Gillespie RS. Resuscitation with hydroxyethyl starch improves renal function and lactate clearance in penetrating trauma in a randomized controlled study: the FIRST trial (Fluids in Resuscitation of Severe Trauma). Br J Anaesth 2011; 107: 693-702.
26. Guidet B, Martinet O, Boulain T et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 2012; 16: R94.
27. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2007; (4): CD000567.
28. Shafer SL. Notice of retraction. Anesth Analg 2010; 111: 1567.
29. Shafer SL. Shadow of doubt. Anesth Analg 2011; 112: 498-500.
30. Myburgh J. CHEST and the impact of fraud in fluid resuscitation research. Crit Care Resusc 2011; 13: 69-70.
31. Haase N, Perner A, Hennings LI et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013; 346: f839.
32. Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4 and 130/0.42) in acutely ill patients: systematic review of effects on mortality and treatment with renal replacement therapy. Intensive Care Med 2013; 39: 558-68.
33. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2012; 6: CD000567.
34. Mutter TC, Ruth CA, Dart AB. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2013; 7: CD007594.
35. Bellomo R, Bion J, Finfer S, Myburgh J, Perner A, Reinhart K. Open letter to the Executive Director of the European Medicines Agency concerning the licensing of hydroxyethyl starch solutions for fluid resuscitation. Br J Anaesth 2014; 112: 595-600.
36. Annane D, Siami S, Jaber S et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 2013; 310: 1809-17.
37. Bion J, Bellomo R, Myburgh J, Perner A, Reinhart K, Finfer S. Hydroxyethyl starch: putting patient safety first. Intensive Care Med 2013; 40: 256-59.
38. Dellinger RP, Levy MM, Rhodes A et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39: 165-228.
39. American College of Surgeons Committee on Trauma. Advanced Trauma Life Support for Doctors. American College of Surgeons Committee on Trauma, 2012. (http://www.facs.org/trauma/atls/index.html).
40. Arlati S, Storti E, Pradella V, Bucci L, Vitolo A, Pulici M. Decreased fluid volume to reduce organ damage: a new approach to burn shock resuscitation? A preliminary study Resuscitation 2007; 72: 371-8.
41. Chua HR, Venkatesh B, Stachowski E et al. Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis. J Crit Care 2012; 27: 138-45.
42. Powell-Tuck J, Gosling P, Lobo DN. et al. British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients (GIFTASUP). March, 2011. (http://www.baden.org.uk/pdfs.bapen_pubs/giftasup.pdf).
43. Hadimioglu N, Saadawy I, Saglam T, Ertug Z, Dinckan A. The effect of different crystalloid solutions on acid-base balance and early kidney function after kidney transplantation. Anesth Analg 2008; 107: 264-9.
44. Kellum JA, Song M, Li J. Science review: extracellular acidosis and the immune response: clinical and physiologic implications. Crit Care 2004; 8: 331-6.
45. Yunos NM, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308: 1566-72.
46. Raghunathan K, Shaw A, Nathanson B et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis*. Crit Care Med 2014; 42: 1585-91.
47. Shaw AD, Bagshaw SM, Goldstein SL et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012; 255: 821-9.
48. Guidet B, Soni N, Della RG et al. A balanced view of balanced solutions. Crit Care 2010; 14: 325.
49. Vincent JL, De BD. Circulatory shock. N Engl J Med 2013; 369: 1726-34.
50. Yealy DM, Kellum JA, Huang DT et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014; 370: 1683-93.
51. Maitland K, George E, Evans J et al. Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Med 2013; 11: 68.
52. Myburgh J, Finfer S. Causes of death after fluid bolus resuscitation: new insights from FEAST. BMC Med 2013; 11: 67.
53. Prowle JR, Bellomo R. Fluid administration and the kidney. Curr Opin Crit Care 2010; 16: 332-6.
54. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011; 39: 259-65.
55. Wiedemann HP, Wheeler AP, Bernard GR et al. Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 2006; 354: 2564-75.
56. Brandstrup B, Svendsen PE, Rasmussen M et al. Which goal for fluid therapy during colorectal surgery is followed by the best outcome: near-maximal stroke volume or zero fluid balance? Br J Anaesth 2012; 109: 191-9.
57. Mikkelsen ME, Christie JD, Lanken PN et al. The adult respiratory distress syndrome cognitive outcomes study: long-term neuropsychological function in survivors of acute lung injury. Am J Respir Crit Care Med 2012; 185: 1307-15.